Dornase Alfa and Urokinase for Kids With Pleural Empyema
Status:
Unknown status
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether intrapleural treatment with Dornase alfa
plus Urokinase improves clinical outcome compared to Urokinase alone in children with
complicated parapneumonic effusions